<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-11T15:32:23+00:00">
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-DJI-C-UNDP-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Investing for impact against HIV and Tuberculosis  in Djibouti - Djibouti (01-Jan-2016-30-Jun-2018)</narrative>
    </title>
    <description type="1">
      <narrative>HIV and AIDS is a major public health problem in the Republic of Djibouti: there is a generalized epidemic with an estimated prevalence level of 2.9 percent and concentrated among some population at higher risk (2014 IBBS study estimating the prevalence of HIV among female sex workers at 13%).  With regards to tuberculosis (TB), Djibouti is ranked fifth in the world in terms of TB incidence and additionally, has a high incidence of TB/HIV co-infection.  Furthermore, the level of multidrug-resistant tuberculosis (MDR-TB) is estimated at 3.7 in new cases and 37.8 in previously treated cases, according to a newly conducted Drug Resistance Survey.  This TB/HIV grant will focus on reducing new HIV infections by targeting both the general population and key populations, through behavioral change activities which will include condom promotion, counselling and testing, and diagnostic and treatment of sexually transmitted infections (STIs).  Moreover, the program will scale out access to treatment and care for people living with HIV, including pregnant women, children and co-infected patients.  With regards to the TB component, the program aims at increasing the detection rate among the general population and key populations, such as refugees and prisoners.  In addition, it will provide diagnostic, treatment and care for drug-resistant TB.</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Reduce by 25 percent TB prevalence by 2025; Reduce by 50 percent new HIV infections by 2017. Objectives: A 50 percent reduction in new HIV infections and the elimination of mother-to-child HIV transmission by the end of 2017; An improvement in the quality of life of PLHIV who are on ARV treatment: 80 percent of eligible PLHIV by the end of 2017; Ensure that the prevalence rate of primary resistance among new cases does not exceed 1.8 percent between now and 2019; Improve the screening of new TB cases so that more than 5,000 new cases are notified in 2019; Improve the treatment success rate, achieving a rate above 85 percent from 2016 and maintaining it up until 2019; Stronger coordination, governance, management, monitoring and evaluation in order to improve the national response at the central and decentralized levels by the end of 2017.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="40" role="2" crs-channel-code="41000">
      <narrative>United Nations Development Programme</narrative>
    </participating-org>
    <participating-org type="40" role="4" crs-channel-code="41000">
      <narrative>United Nations Development Programme</narrative>
    </participating-org>
    <other-identifier ref="DJI-C-UNDPP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2016-01-01" />
    <activity-date type="2" iso-date="2016-01-01" />
    <activity-date type="3" iso-date="2018-06-30" />
    <activity-date type="4" iso-date="2018-06-30" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Nathalie Brechet</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>nathalie.brechet@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="DJ" percentage="100">
      <narrative>Djibouti</narrative>
    </recipient-country>
    <sector vocabulary="1" code="13040" percentage="50">
      <narrative>TB/HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="50">
      <narrative>TB/HIV</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <transaction ref="8b8a1157-1738-42dc-8a84-7a963af94cdc">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-02-18" />
      <value currency="USD" value-date="2016-02-18">6853574.00</value>
      <description>
        <narrative>Global Fund commitment to DJI-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5410b796-c406-4920-935d-565f01492795">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-02-19" />
      <value currency="USD" value-date="2016-02-19">3065401.00</value>
      <description>
        <narrative>Global Fund disbursement to DJI-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="075574b8-a8e8-4613-b2c3-1adcf6536327">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-08-23" />
      <value currency="USD" value-date="2016-08-23">1400314.00</value>
      <description>
        <narrative>Global Fund disbursement to DJI-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0301433e-cf53-49c7-822f-cb9ca3957ba7">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-05-23" />
      <value currency="USD" value-date="2017-05-23">2387859.00</value>
      <description>
        <narrative>Global Fund disbursement to DJI-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="dbe0b5d5-3892-42e5-8c67-2502014af97a">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-11-15" />
      <value currency="USD" value-date="2017-11-15">537262.70</value>
      <description>
        <narrative>Global Fund commitment to DJI-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0794c87e-90a3-4e12-9ab5-d89f345d7161">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-11-16" />
      <value currency="USD" value-date="2017-11-16">364316.70</value>
      <description>
        <narrative>Global Fund disbursement to DJI-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bbea7fcc-9a67-456d-966f-b4348156bbdc">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-12-15" />
      <value currency="USD" value-date="2017-12-15">25000.00</value>
      <description>
        <narrative>Global Fund commitment to DJI-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3ec55e9a-56b5-40b5-895a-5f8406ea92e1">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-04-13" />
      <value currency="USD" value-date="2018-04-13">-25000.00</value>
      <description>
        <narrative>Global Fund commitment to DJI-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6520d3ae-4f5e-40fd-8ae4-7667000179cd">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-06-12" />
      <value currency="USD" value-date="2018-06-12">172946.00</value>
      <description>
        <narrative>Global Fund disbursement to DJI-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/DJI-C-UNDP" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31" value="31" />
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="57" />
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="57" />
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="63" />
          <actual value="39" />
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="63" />
          <actual value="36" />
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="46" />
          <actual value="23" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative>
      </title>
      <description>
        <narrative>Module: PMTCT.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="53.4">
          <comment>
            <narrative>Numerator: 55; Denominator: 103.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="95.4">
            <comment>
              <narrative>Numerator: 83; Denominator: 87.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="95.4">
            <comment>
              <narrative>Numerator: 83; Denominator: 87.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 154; Denominator: 154.</narrative>
            </comment>
          </target>
          <actual value="78.4">
            <comment>
              <narrative>Numerator: 29; Denominator: 37.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 154; Denominator: 154.</narrative>
            </comment>
          </target>
          <actual value="92">
            <comment>
              <narrative>Numerator: 23; Denominator: 25.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="65.08">
            <comment>
              <narrative>Numerator: 82; Denominator: 126.</narrative>
            </comment>
          </target>
          <actual value="87.5">
            <comment>
              <narrative>Numerator: 28; Denominator: 32.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="1241" />
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="684" />
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="684" />
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="752" />
          <actual value="471" />
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="752" />
          <actual value="602" />
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="809" />
          <actual value="529" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31" value="82.16">
          <comment>
            <narrative>Numerator: 921; Denominator: 1121.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="85.06">
            <comment>
              <narrative>Numerator: 501; Denominator: 589.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="85.06">
            <comment>
              <narrative>Numerator: 501; Denominator: 589.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="85.03">
            <comment>
              <narrative>Numerator: 551; Denominator: 648.</narrative>
            </comment>
          </target>
          <actual value="87.3">
            <comment>
              <narrative>Numerator: 433; Denominator: 496.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="85.03">
            <comment>
              <narrative>Numerator: 551; Denominator: 648.</narrative>
            </comment>
          </target>
          <actual value="85.2">
            <comment>
              <narrative>Numerator: 468; Denominator: 549.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="87.16">
            <comment>
              <narrative>Numerator: 353; Denominator: 405.</narrative>
            </comment>
          </target>
          <actual value="79.5">
            <comment>
              <narrative>Numerator: 321; Denominator: 404.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="76.27">
          <comment>
            <narrative>Numerator: 90; Denominator: 118.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="90.32">
            <comment>
              <narrative>Numerator: 84; Denominator: 93.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="90.32">
            <comment>
              <narrative>Numerator: 84; Denominator: 93.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 102; Denominator: 102.</narrative>
            </comment>
          </target>
          <actual value="75.4">
            <comment>
              <narrative>Numerator: 52; Denominator: 69.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 102; Denominator: 102.</narrative>
            </comment>
          </target>
          <actual value="70.8">
            <comment>
              <narrative>Numerator: 46; Denominator: 65.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="90.63">
            <comment>
              <narrative>Numerator: 58; Denominator: 64.</narrative>
            </comment>
          </target>
          <actual value="73.8">
            <comment>
              <narrative>Numerator: 48; Denominator: 65.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV and on ART, who have a suppressed viral load at 12 months (&lt;1000 copies/ml)</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV and on ART, who have a suppressed viral load at 12 months (&lt;1000 copies/ml)</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="79.45">
          <comment>
            <narrative>Numerator: 58; Denominator: 73.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="79.84">
            <comment>
              <narrative>Numerator: 99; Denominator: 124.</narrative>
            </comment>
          </target>
          <actual value="46.7">
            <comment>
              <narrative>Numerator: 7; Denominator: 15.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="24.77">
          <comment>
            <narrative>Numerator: 1593; Denominator: 6430.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="30.32">
            <comment>
              <narrative>Numerator: 2036; Denominator: 6714.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="32.93">
            <comment>
              <narrative>Numerator: 2211; Denominator: 6714.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="34.93">
            <comment>
              <narrative>Numerator: 2411; Denominator: 6903.</narrative>
            </comment>
          </target>
          <actual value="34.2">
            <comment>
              <narrative>Numerator: 2360; Denominator: 6903.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="37.82">
            <comment>
              <narrative>Numerator: 2611; Denominator: 6903.</narrative>
            </comment>
          </target>
          <actual value="35.6">
            <comment>
              <narrative>Numerator: 2454; Denominator: 6903.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="36.13">
            <comment>
              <narrative>Numerator: 2973; Denominator: 8229.</narrative>
            </comment>
          </target>
          <actual value="31">
            <comment>
              <narrative>Numerator: 2554; Denominator: 8229.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-DJI-C-UNDP-2</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Support the National HIV and Tuberculosis Programmes in scaling up treatment and care services nationwide - Djibouti (01-Jul-2018-31-Dec-2020)</narrative>
    </title>
    <description type="1">
      <narrative>Djibouti, TB/HIV, United Nations Development Programme</narrative>
    </description>
    <description type="2">
      <narrative>Goals: To reduce the prevalence of tuberculosis by 25% by 2025; To halve new HIV infections by 2022; To improve the life expectancy and quality of life for people infected and affected by HIV and comorbidity agents. Objectives: To improve screening for new cases of tuberculosis with a view to reporting 3200 new cases by 2020; To improve treatment success to achieve a rate in excess of 85% from 2016 and to maintain it at that level until 2020; To ensure that the prevalence of primary resistance amongst new cases does not exceed 1.8% between now and 2020; To reduce the death rate among cases of co-infection from 17% to 15% by 2020; For the incidence of HIV to halve by 2022; For the HIV mortality rate to be reduced by 70% by 2022.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="40" role="2" crs-channel-code="41000">
      <narrative>United Nations Development Programme</narrative>
    </participating-org>
    <participating-org type="40" role="4" crs-channel-code="41000">
      <narrative>United Nations Development Programme</narrative>
    </participating-org>
    <other-identifier ref="DJI-C-UNDPP02" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2018-07-01" />
    <activity-date type="2" iso-date="2018-07-01" />
    <activity-date type="3" iso-date="2020-12-31" />
    <activity-date type="4" iso-date="2020-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Nathalie Brechet</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>nathalie.brechet@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="DJ" percentage="100">
      <narrative>Djibouti</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12110" percentage="37.32">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="13040" percentage="32.92">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="29.76">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="732c3707-c5a2-4b8c-9650-f713d3a87712" percentage="1.35">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Differentiated HIV testing services</narrative>
        </description>
      </budget-item>
      <budget-item code="88e84f39-6ecb-44f6-8d85-0c0c6661a758" percentage="0.06">
        <description>
          <narrative>HIV -&gt; PMTCT -&gt; Other intervention(s) for PMTCT</narrative>
        </description>
      </budget-item>
      <budget-item code="43040121-7c59-4d93-9b1a-708f68d30073" percentage="0.25">
        <description>
          <narrative>HIV -&gt; PMTCT -&gt; Prong 1: Primary prevention of HIV infection among women of childbearing age</narrative>
        </description>
      </budget-item>
      <budget-item code="8c083672-6c28-419d-af9f-7a0d83a25bef" percentage="0.45">
        <description>
          <narrative>HIV -&gt; PMTCT -&gt; Prong 2: Preventing unintended pregnancies among women living with HIV</narrative>
        </description>
      </budget-item>
      <budget-item code="925d8e7c-f7a1-4507-b75d-6e254720fa3f" percentage="0.2">
        <description>
          <narrative>HIV -&gt; PMTCT -&gt; Prong 3: Preventing vertical HIV transmission</narrative>
        </description>
      </budget-item>
      <budget-item code="199097c3-8576-47ad-8496-edbc492fc089" percentage="0.46">
        <description>
          <narrative>HIV -&gt; PMTCT -&gt; Prong 4: Treatment, care and support to mothers living with HIV, their children and families</narrative>
        </description>
      </budget-item>
      <budget-item code="a043623f-0c87-42d4-8d1a-14144145ecb6" percentage="1.77">
        <description>
          <narrative>HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Behavioral change as part of programs for adolescent and youth</narrative>
        </description>
      </budget-item>
      <budget-item code="d3f0ee90-71c1-4dad-ad46-19e91d25c002" percentage="23.55">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV care</narrative>
        </description>
      </budget-item>
      <budget-item code="e53ba535-c657-45be-8818-ca510aadaba3" percentage="2.1">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Other intervention(s) for treatment</narrative>
        </description>
      </budget-item>
      <budget-item code="5617b892-3d6e-42d5-8005-bd04d04e2f7e" percentage="0.32">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Prevention, diagnosis and treatment of opportunistic infections</narrative>
        </description>
      </budget-item>
      <budget-item code="c7d050d8-ddb8-42db-a948-04038ae9cd0f" percentage="2.42">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load</narrative>
        </description>
      </budget-item>
      <budget-item code="e07bbbe4-54fa-4084-a6fe-7f1c9c3b77b6" percentage="31.14">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="c9a33ca8-7a81-4232-9a19-1315956af36c" percentage="2.53">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
        </description>
      </budget-item>
      <budget-item code="043741b4-bd0a-492c-8759-b4cac0a50e64" percentage="0.03">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Other health information systems and M&amp;E intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="004842a6-d6eb-49a2-a763-882fd356689a" percentage="2.92">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="a917e4f1-a1df-4b72-a335-1d4b3db2d854" percentage="0.71">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Supply chain infrastructure and development of tools</narrative>
        </description>
      </budget-item>
      <budget-item code="1c7b99cb-f18c-499f-a55d-f7a0d6b99b21" percentage="4.47">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="8bfd5db3-426b-4dc3-aec1-929f85b850a4" percentage="0.54">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Other MDR-TB intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="3637a37c-6acc-4a5b-b7e4-00640fd7e2ec" percentage="4.06">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="f7014493-22e9-4c03-96d0-144fbb3a254f" percentage="14.66">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="accfbf9b-023f-4bd8-b952-bf1cb13e8e9b" percentage="0.48">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="edbef7da-ca99-4741-8ce0-ea3ba6cd3d3b" percentage="3.49">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="13c1e439-070b-4238-9903-7972703a027e" percentage="0.26">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Collaborative activities with other programs and sectors (TB/HIV)</narrative>
        </description>
      </budget-item>
      <budget-item code="210d51b7-40a1-4b35-b1fe-14cb15713360" percentage="0.13">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Key populations (TB/HIV) - Prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="92e11022-488c-4948-abb3-b61f3d9ca4f6" percentage="1.65">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2018-01-01" />
      <period-end iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-01-01">735851.39</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2019-01-01" />
      <period-end iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-01-01">1791342.09</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2020-01-01" />
      <period-end iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-01-01">2389230.51</value>
    </budget>
    <capital-spend percentage="4.29" />
    <transaction ref="a96c458a-c358-4429-92dd-e493a25307cc">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-10-05" />
      <value currency="USD" value-date="2018-10-05">25000.00</value>
      <description>
        <narrative>Global Fund commitment to DJI-C-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="995fe896-ade9-4838-a544-1eb373e38594">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-10-09" />
      <value currency="USD" value-date="2018-10-09">1400947.85</value>
      <description>
        <narrative>Global Fund commitment to DJI-C-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d368f1e1-1eeb-4f3b-8d62-23c7a41bf342">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-10-11" />
      <value currency="USD" value-date="2018-10-11">1114620.85</value>
      <description>
        <narrative>Global Fund disbursement to DJI-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c8ec0844-dd73-4205-a646-78f3a8e47d08">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-10-19" />
      <value currency="USD" value-date="2018-10-19">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to DJI-C-UNDPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4d710f00-b3df-45d5-b503-654f140d3a3a">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-11-15" />
      <value currency="USD" value-date="2018-11-15">286327.00</value>
      <description>
        <narrative>Global Fund disbursement to DJI-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="388f995b-73da-4967-9322-c47af03973ef">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-11-26" />
      <value currency="USD" value-date="2018-11-26">398844.00</value>
      <description>
        <narrative>Global Fund commitment to DJI-C-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d2dbc324-4e37-43a6-9399-65e2074b8671">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-11-27" />
      <value currency="USD" value-date="2018-11-27">398844.00</value>
      <description>
        <narrative>Global Fund disbursement to DJI-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2fdbf158-7838-46df-bcbc-ee06772e6fdd">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-08-07" />
      <value currency="USD" value-date="2019-08-07">25000.00</value>
      <description>
        <narrative>Global Fund commitment to DJI-C-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6f8ca69f-8bb3-4f2e-8cf9-cd45dc22aa9a">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-09-25" />
      <value currency="USD" value-date="2019-09-25">2386282.49</value>
      <description>
        <narrative>Global Fund commitment to DJI-C-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c33a60fc-07f4-4d82-9b97-deab359f1021">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-09-26" />
      <value currency="USD" value-date="2019-09-26">1324573.64</value>
      <description>
        <narrative>Global Fund disbursement to DJI-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5f596384-aff8-4c33-bb3d-a99202af2c27">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-10-10" />
      <value currency="USD" value-date="2019-10-10">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to DJI-C-UNDPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="db6ebd31-20e4-482d-8c5b-b11f13bb9ed5">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-02-11" />
      <value currency="USD" value-date="2020-02-11">684025.50</value>
      <description>
        <narrative>Global Fund disbursement to DJI-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c8b242a0-08dd-492e-83dd-399527cddf35">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-04-21" />
      <value currency="USD" value-date="2020-04-21">377683.35</value>
      <description>
        <narrative>Global Fund disbursement to DJI-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="77a11969-30da-4444-a459-8d899342ca0f">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-06-18" />
      <value currency="USD" value-date="2020-06-18">410458.57</value>
      <description>
        <narrative>Global Fund commitment to DJI-C-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="41d33bb9-7d1b-424e-9172-0e8d92cb9482">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-06-24" />
      <value currency="USD" value-date="2020-06-24">410458.57</value>
      <description>
        <narrative>Global Fund disbursement to DJI-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="105f5f40-5b7d-4cb2-8bae-80d760c4398b">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-09-01" />
      <value currency="USD" value-date="2021-09-01">604.54</value>
      <description>
        <narrative>Funds returned to the Global Fund from DJI-C-UNDPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7e3fa69b-80ca-48cd-8ea7-546e2438740e">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-09-30" />
      <value currency="USD" value-date="2021-09-30">-604.54</value>
      <description>
        <narrative>Global Fund commitment to DJI-C-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="DJI-C-UNDPP02-EXP-20181231">
      <transaction-type code="4" />
      <transaction-date iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-12-31">735851.00</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for DJI-C-UNDPP02, Jul 2018 to Dec 2018.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="DJI-C-UNDPP02-EXP-20191231">
      <transaction-type code="4" />
      <transaction-date iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-12-31">1791342.08</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for DJI-C-UNDPP02, Jan 2019 to Dec 2019.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="DJI-C-UNDPP02-EXP-20201231">
      <transaction-type code="4" />
      <transaction-date iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-12-31">2318985.78</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for DJI-C-UNDPP02, Jan 2020 to Dec 2020.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="DJI-C-UNDPP02-EXP-20210630">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-06-30" />
      <value currency="USD" value-date="2021-06-30">16086.95</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for DJI-C-UNDPP02, Jan 2021 to Jun 2021.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/DJI-C-UNDP" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people who were tested for HIV and received their results during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people who were tested for HIV and received their results during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="24401" />
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="13421" />
          <actual value="16036" />
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target value="29525" />
          <actual value="26535" />
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="32478" />
          <actual value="22170" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="71" />
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="36" />
          <actual value="41" />
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target value="72" />
          <actual value="49" />
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="70" />
          <actual value="53" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="71" />
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="36" />
          <actual value="40" />
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target value="72" />
          <actual value="44" />
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="70" />
          <actual value="49" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative>
      </title>
      <description>
        <narrative>Module: PMTCT.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="48.85">
          <comment>
            <narrative>Numerator: 85; Denominator: 174.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="50">
            <comment>
              <narrative>Numerator: 63; Denominator: 126.</narrative>
            </comment>
          </target>
          <actual value="17.5">
            <comment>
              <narrative>Numerator: 22; Denominator: 126.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target value="54.85">
            <comment>
              <narrative>Numerator: 147; Denominator: 268.</narrative>
            </comment>
          </target>
          <actual value="33.9">
            <comment>
              <narrative>Numerator: 41; Denominator: 121.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="60.53">
            <comment>
              <narrative>Numerator: 69; Denominator: 114.</narrative>
            </comment>
          </target>
          <actual value="44.7">
            <comment>
              <narrative>Numerator: 51; Denominator: 114.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="2523" />
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="1134" />
          <actual value="1013" />
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target value="2269" />
          <actual value="1825" />
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="2261" />
          <actual value="1701" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="79.3">
          <comment>
            <narrative>Numerator: 410; Denominator: 517.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <actual value="84.8">
            <comment>
              <narrative>Numerator: 895; Denominator: 1056.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target value="84.97">
            <comment>
              <narrative>Numerator: 1928; Denominator: 2269.</narrative>
            </comment>
          </target>
          <actual value="84.2">
            <comment>
              <narrative>Numerator: 1683; Denominator: 1999.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="90.31">
            <comment>
              <narrative>Numerator: 2042; Denominator: 2261.</narrative>
            </comment>
          </target>
          <actual value="82.2">
            <comment>
              <narrative>Numerator: 1500; Denominator: 1825.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="76.27">
          <comment>
            <narrative>Numerator: 90; Denominator: 118.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="90.2">
            <comment>
              <narrative>Numerator: 46; Denominator: 51.</narrative>
            </comment>
          </target>
          <actual value="65.9">
            <comment>
              <narrative>Numerator: 27; Denominator: 41.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target value="95.19">
            <comment>
              <narrative>Numerator: 99; Denominator: 104.</narrative>
            </comment>
          </target>
          <actual value="75.5">
            <comment>
              <narrative>Numerator: 74; Denominator: 98.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 95; Denominator: 100.</narrative>
            </comment>
          </target>
          <actual value="63">
            <comment>
              <narrative>Numerator: 51; Denominator: 81.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV and on ART, who have a suppressed viral load at 12 months (&lt;1000 copies/ml)</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV and on ART, who have a suppressed viral load at 12 months (&lt;1000 copies/ml)</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="22.14">
          <comment>
            <narrative>Numerator: 58; Denominator: 262.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 160; Denominator: 200.</narrative>
            </comment>
          </target>
          <actual value="20">
            <comment>
              <narrative>Numerator: 23; Denominator: 115.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target value="85">
            <comment>
              <narrative>Numerator: 425; Denominator: 500.</narrative>
            </comment>
          </target>
          <actual value="11.9">
            <comment>
              <narrative>Numerator: 27; Denominator: 226.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 540; Denominator: 600.</narrative>
            </comment>
          </target>
          <actual value="11.5">
            <comment>
              <narrative>Numerator: 26; Denominator: 227.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="31.98">
          <comment>
            <narrative>Numerator: 2229; Denominator: 6971.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="35.85">
            <comment>
              <narrative>Numerator: 2950; Denominator: 8229.</narrative>
            </comment>
          </target>
          <actual value="32.6">
            <comment>
              <narrative>Numerator: 2680; Denominator: 8229.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target value="41.81">
            <comment>
              <narrative>Numerator: 3450; Denominator: 8252.</narrative>
            </comment>
          </target>
          <actual value="42.8">
            <comment>
              <narrative>Numerator: 2907; Denominator: 6799.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="49.4">
            <comment>
              <narrative>Numerator: 3263; Denominator: 6605.</narrative>
            </comment>
          </target>
          <actual value="31.2">
            <comment>
              <narrative>Numerator: 2063; Denominator: 6605.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>